European Association of Urology (EAU21) Virtual Congress

Virtual 08 July 2021 - 12 July 2021

Obesity may influence survival in metastatic castration-resistant prostate cancer

08 Sep 2021 by

The obesity paradox, where obesity appears to confer a protective effect, was noted in metastatic castration-resistant prostate cancer (CRPC), with improved survival outcomes among obese patients with metastatic CRPC, according to a study from EAU21.

Obesity may influence survival in metastatic castration-resistant prostate cancer

08 Sep 2021

Outcomes of active surveillance for prostate cancer may vary with age

07 Sep 2021 by

The benefits of active surveillance for prostate cancer appear to be greater in men diagnosed with low-risk prostate cancer at an older age, according to a study from Sweden.

Outcomes of active surveillance for prostate cancer may vary with age

07 Sep 2021

MRI-targeted biopsy + new risk score cuts unnecessary biopsies in prostate cancer

07 Sep 2021 by

An MRI-targeted biopsy* plus a new risk score cuts unnecessary biopsies by half in men with positive MRI results and elevated PSA** levels in the STHLM3-MRI study. This benefit comes without missing clinically significant cancers, experts report at EAU 2021.

MRI-targeted biopsy + new risk score cuts unnecessary biopsies in prostate cancer

07 Sep 2021

High urine cotinine levels may signal bladder cancer recurrence

26 Aug 2021 by

High levels of cotinine in the urine of smokers who have undergone resection for non-muscle invasive bladder cancer (NMIBC) could be a sign of cancer recurrence, according to a study from Lebanon presented at EAU21.

High urine cotinine levels may signal bladder cancer recurrence

26 Aug 2021

AbobotulinumtoxinA cuts incontinence episodes in patients with NDOI

20 Aug 2021 by

In individuals with neurogenic detrusor overactivity incontinence (NDOI) who were regularly undergoing clean intermittent catheterization, significant reductions of urinary incontinence episodes were seen following treatment with abobotulinumtoxinA (aboBoNT-A), according to a pooled analysis of two CONTENT studies presented at EAU 2021.

AbobotulinumtoxinA cuts incontinence episodes in patients with NDOI

20 Aug 2021

Botulinum toxin type A may reduce incontinence episodes

19 Aug 2021 by

In a systematic review and meta-analysis of randomized controlled trials (RCTs) presented at EAU 2021, the use of botulinum toxin (BTX) type A in individuals with neurogenic detrusor overactivity (NDO) and idiopathic overactive bladder (iOAB) led to a reduction in incontinence episodes.

Botulinum toxin type A may reduce incontinence episodes

19 Aug 2021

MV140 bacterial vaccine reduces UTI frequency in women

18 Aug 2021 by

The sublingual bacterial vaccine MV140 reduces the number of recurrent urinary tract infections (UTIs) in women, according to a European study presented at EAU21.

MV140 bacterial vaccine reduces UTI frequency in women

18 Aug 2021

Testosterone therapy in hypogonadal men: Good for the heart and kidneys?

11 Aug 2021 by

Testosterone replacement therapy (TRT) reduces the risks of major adverse cardiovascular events (MACE) and deaths in hypogonadal men, according to long-term data reported at EAU21.

Testosterone therapy in hypogonadal men: Good for the heart and kidneys?

11 Aug 2021

Has COVID-19 changed the pathological outcomes in prostate cancer?

05 Aug 2021 by

The likelihood of pT3* or higher tumours and node-positive disease found at the time of radical prostatectomy (RP) for prostate cancer (PCa) was greater during the COVID-19 pandemic than it was before, an expert reported at EAU21.

Has COVID-19 changed the pathological outcomes in prostate cancer?

05 Aug 2021